SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-108304
Filing Date
2016-03-29
Accepted
2016-03-29 16:43:07
Documents
3
Period of Report
2016-03-29
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-7289_18k.htm 8-K 28776
2 EX-3.1 a16-7289_1ex3d1.htm EX-3.1 38865
3 EX-3.2 a16-7289_1ex3d2.htm EX-3.2 236173
  Complete submission text file 0001104659-16-108304.txt   305011
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 161535793
SIC: 2834 Pharmaceutical Preparations